跳至主要内容
临床试验/NCT00764829
NCT00764829已完成不适用

Blood Samples to Evaluate Biomarkers of Donor Chimerism

Fred Hutchinson Cancer Center1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2008年9月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
80
试验地点
1
主要终点
Donor T-cell chimerism

研究概览

简要总结

We are interested in patient-specific factors that may affect the balance of recipient cells and donor cells in patients who receive stem cell transplants. We will look at the way the patient's body breaks down two drugs, fludarabine and mycophenolate mofetil, and how these two drugs affect the patient's body.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosed with a hematologic disease or malignancy
  • Scheduled to receive nonablative conditioning with fludarabine and total body irradiation
  • Donor is well-matched by high resolution DNA techniques.
  • Scheduled to receive postgrafting immunosuppression of oral MMF (CellCept) and an oral calcineurin inhibitor.
  • Age >18 years at the time of enrollment.
  • Exclusion criteria:
  • Diagnosed with an immunodeficiency disorder

排除标准

  • 未提供

结局指标

主要结局

Donor T-cell chimerism

时间窗: Day 28 post-transplant

次要结局

  • Exposure to fludarabine and mycophenolate mofetil and their breakdown products.(Before and after transplant)

研究者

申办方类型
Other

研究点 (1)

Loading locations...

相似试验